Qing Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Qing Xie has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Lingyang Hua
Department of Neurosurgery of Huashan Hospital, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science and Institutes of Brain Science, Fudan University, Shanghai, China
7 shared publicationsHailiang Tang
Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, People's Republic of China
6 shared publications- Ye Gong
Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
6 shared publications Hongda Zhu
Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, People's Republic of China
5 shared publicationsShihai Luan
Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, People's Republic of China
4 shared publicationsHong Chen
Department of Neuropathology, Huashan Hospital, Fudan University, Shanghai, China
2 shared publications
Latest Publications
- 19 October 2023
- Published by Springer Nature in European Radiology
- Vol. 34 (5) , 2997-3008
Predicting meningioma grades and pathologic marker expression via deep learning
Objectives To establish a deep learning (DL) model for predicting tumor grades and expression of pathologic markers of meningioma. Methods A total of 1192 meningioma patients from two centers who underwent surgical resection between September 2018 and December 2021 were retrospectively included. The pathological data and post-contrast T1-weight images for each patient were collected. The patients from institute I were subdivided into training, validation, and testing sets, while the patients from institute II served as the external testing cohort. The fine-tuned ResNet50 model based on transfer learning was adopted to classify WHO grade in the whole cohort and predict Ki-67 index, H3K27me3, and progesterone receptor (PR) status of grade 1 meningiomas. The predictive performance was evaluated by the accuracy and loss curve, confusion matrix, receiver operating characteristic curve (ROC), and area under curve (AUC). Results The DL prediction model for each label achieved high predictive performance in two cohorts. For WHO grade prediction, the area under the curve (AUC) was 0.966 (95%CI 0.957–0.975) in the internal testing set and 0.669 (95%CI 0.643–0.695) in the external validation cohort. The AUC in predicting Ki-67 index, H3K27me3, and PR status were 0.905 (95%CI 0.895–0.915), 0.773 (95%CI 0.760–0.786), and 0.771 (95%CI 0.750–0.792) in the internal testing set and 0.591 (95%CI 0.562–0.620), 0.658 (95%CI 0.648–0.668), and 0.703 (95%CI 0.674–0.732) in the external validation cohort, respectively. Conclusion DL models can preoperatively predict meningioma grades and pathologic marker expression with favorable predictive performance. Clinical relevance statement Our DL model could predict meningioma grades and expression of pathologic markers and identify high-risk patients with WHO grade 1 meningioma, which would suggest a more aggressive operative intervention preoperatively and a more frequent follow-up schedule postoperatively. Key Points WHO grades and some pathologic markers of meningioma were associated with therapeutic strategies and clinical outcomes. A deep learning–based approach was employed to develop a model for predicting meningioma grades and the expression of pathologic markers. Preoperative prediction of meningioma grades and the expression of pathologic markers was beneficial for clinical decision-making.
- 19 October 2023
- Published by Springer Nature in European Radiology
- Vol. 34 (5) , 2997-3008
Predicting meningioma grades and pathologic marker expression via deep learning
Objectives To establish a deep learning (DL) model for predicting tumor grades and expression of pathologic markers of meningioma. Methods A total of 1192 meningioma patients from two centers who underwent surgical resection between September 2018 and December 2021 were retrospectively included. The pathological data and post-contrast T1-weight images for each patient were collected. The patients from institute I were subdivided into training, validation, and testing sets, while the patients from institute II served as the external testing cohort. The fine-tuned ResNet50 model based on transfer learning was adopted to classify WHO grade in the whole cohort and predict Ki-67 index, H3K27me3, and progesterone receptor (PR) status of grade 1 meningiomas. The predictive performance was evaluated by the accuracy and loss curve, confusion matrix, receiver operating characteristic curve (ROC), and area under curve (AUC). Results The DL prediction model for each label achieved high predictive performance in two cohorts. For WHO grade prediction, the area under the curve (AUC) was 0.966 (95%CI 0.957–0.975) in the internal testing set and 0.669 (95%CI 0.643–0.695) in the external validation cohort. The AUC in predicting Ki-67 index, H3K27me3, and PR status were 0.905 (95%CI 0.895–0.915), 0.773 (95%CI 0.760–0.786), and 0.771 (95%CI 0.750–0.792) in the internal testing set and 0.591 (95%CI 0.562–0.620), 0.658 (95%CI 0.648–0.668), and 0.703 (95%CI 0.674–0.732) in the external validation cohort, respectively. Conclusion DL models can preoperatively predict meningioma grades and pathologic marker expression with favorable predictive performance. Clinical relevance statement Our DL model could predict meningioma grades and expression of pathologic markers and identify high-risk patients with WHO grade 1 meningioma, which would suggest a more aggressive operative intervention preoperatively and a more frequent follow-up schedule postoperatively. Key Points WHO grades and some pathologic markers of meningioma were associated with therapeutic strategies and clinical outcomes. A deep learning–based approach was employed to develop a model for predicting meningioma grades and the expression of pathologic markers. Preoperative prediction of meningioma grades and the expression of pathologic markers was beneficial for clinical decision-making.
- Open Access
- 1 October 2019
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 11, 9185-9193
The Diagnostic Value Of Using 18F-Fluorodeoxyglucose Positron Emission Tomography To Differentiate Between Low- And High-Grade Meningioma
Objective: This study aims to evaluate the potential role of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in detecting high-grade meningiomas and predicting the prognosis of patients after meningioma surgery. Patients and methods: A total of 124 patients met the final inclusion criterion. Tumor to gray ratio (TGR) was compared with Ki-67 labeling index, and its correlations with pre-operative neurological function and treatment status were also evaluated. Receiver-operating characteristic (ROC) curve was drawn to determine a cut-off value which could discriminate meningioma of different grades. Prognostic factors including TGR were analyzed using Kaplan-Meier survival curve and cox proportional model. Results: The TGR of higher World Health Organization (WHO) grade meningioma was significantly higher than that in lower grade (p < 0.001), and it was correlated with the Ki-67 labeling index (p < 0.001, r = 0.1545). The TGR of 1.30 was the best cutoff value for the detection of high grade (WHO grade II&III) meningioma from low grade (WHO grade I) according to ROC analysis, with a sensitivity of 61.5%, the specificity of 86.7%, and accuracy of 81.5%. The TGR (p < 0.001), treatment status (p = 0.035), tumor grade (p < 0.001) and Ki-67 labeling index (p < 0.001) were significantly associated with progression-free survival (PFS). Cox proportional hazards model demonstrated that TGR (p = 0.013) was an independent prognostic factor for PFS. Conclusion: A high uptake of FDG was correlated with a more proliferative biological behavior and is a risk factor for tumor recurrence.
- 1 October 2019
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 11, 9185-9193
Open AccessThe Diagnostic Value Of Using 18F-Fluorodeoxyglucose Positron Emission Tomography To Differentiate Between Low- And High-Grade Meningioma
Objective: This study aims to evaluate the potential role of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in detecting high-grade meningiomas and predicting the prognosis of patients after meningioma surgery. Patients and methods: A total of 124 patients met the final inclusion criterion. Tumor to gray ratio (TGR) was compared with Ki-67 labeling index, and its correlations with pre-operative neurological function and treatment status were also evaluated. Receiver-operating characteristic (ROC) curve was drawn to determine a cut-off value which could discriminate meningioma of different grades. Prognostic factors including TGR were analyzed using Kaplan-Meier survival curve and cox proportional model. Results: The TGR of higher World Health Organization (WHO) grade meningioma was significantly higher than that in lower grade (p < 0.001), and it was correlated with the Ki-67 labeling index (p < 0.001, r = 0.1545). The TGR of 1.30 was the best cutoff value for the detection of high grade (WHO grade II&III) meningioma from low grade (WHO grade I) according to ROC analysis, with a sensitivity of 61.5%, the specificity of 86.7%, and accuracy of 81.5%. The TGR (p < 0.001), treatment status (p = 0.035), tumor grade (p < 0.001) and Ki-67 labeling index (p < 0.001) were significantly associated with progression-free survival (PFS). Cox proportional hazards model demonstrated that TGR (p = 0.013) was an independent prognostic factor for PFS. Conclusion: A high uptake of FDG was correlated with a more proliferative biological behavior and is a risk factor for tumor recurrence.
- Open Access
- 25 January 2019
- Published by Wiley in Cancer Medicine
- Vol. 8 (1) , 13-20
Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma
The effect of adjuvant radiotherapy in management for high‐grade meningiomas, especially atypical meningiomas, remains controversial. We aimed to explore the role of adjuvant radiotherapy in this population. A total of 162 adults with high‐grade meningiomas (99 atypical meningiomas and 63 anaplastic meningiomas) were treated from 2003 to 2008 at Huashan Hospital. One hundred and seventeen patients presented with primary and 45 with recurrent disease. One hundred and fifteen patients (70.9%) were treated with adjuvant radiotherapy after surgical resection. The median follow‐up was 76.5 months (range 1‐142 months). Kaplan‐Meier survival curve and Cox proportional hazards modeling were used for analyses. Adjuvant radiotherapy was associated with prolonged progression‐free survival (PFS) and overall survival (OS) in patients with newly diagnosed anaplastic meningiomas irrespective of extent of resection (PFS, P = .001; OS, P = .003). Gross total resection was the only independent prognostic factor for those with newly diagnosed atypical meningiomas (PFS, P < .001; OS, P = .012). A survival benefit for adjuvant radiation was also found in subgroup analysis of patients with high‐grade meningiomas who underwent subtotal resection (PFS, P = .023; OS, P = .013). Among recurrent high‐grade meningiomas, radiotherapy offered no statistically significant improvement in either PFS or OS. Adjuvant radiotherapy is associated with improved survival in patients with newly diagnosed anaplastic meningiomas and those high‐grade meningiomas following subtotal resection. However, there was no significant correlation identified between postoperative radiation and outcome for recurrent high‐grade meningiomas. Future prospective randomized trials may help clarify the optimal tailored treatment for patients with high‐grade meningioma.
- 25 January 2019
- Published by Wiley in Cancer Medicine
- Vol. 8 (1) , 13-20
Open AccessEfficacy of adjuvant radiotherapy for atypical and anaplastic meningioma
The effect of adjuvant radiotherapy in management for high‐grade meningiomas, especially atypical meningiomas, remains controversial. We aimed to explore the role of adjuvant radiotherapy in this population. A total of 162 adults with high‐grade meningiomas (99 atypical meningiomas and 63 anaplastic meningiomas) were treated from 2003 to 2008 at Huashan Hospital. One hundred and seventeen patients presented with primary and 45 with recurrent disease. One hundred and fifteen patients (70.9%) were treated with adjuvant radiotherapy after surgical resection. The median follow‐up was 76.5 months (range 1‐142 months). Kaplan‐Meier survival curve and Cox proportional hazards modeling were used for analyses. Adjuvant radiotherapy was associated with prolonged progression‐free survival (PFS) and overall survival (OS) in patients with newly diagnosed anaplastic meningiomas irrespective of extent of resection (PFS, P = .001; OS, P = .003). Gross total resection was the only independent prognostic factor for those with newly diagnosed atypical meningiomas (PFS, P < .001; OS, P = .012). A survival benefit for adjuvant radiation was also found in subgroup analysis of patients with high‐grade meningiomas who underwent subtotal resection (PFS, P = .023; OS, P = .013). Among recurrent high‐grade meningiomas, radiotherapy offered no statistically significant improvement in either PFS or OS. Adjuvant radiotherapy is associated with improved survival in patients with newly diagnosed anaplastic meningiomas and those high‐grade meningiomas following subtotal resection. However, there was no significant correlation identified between postoperative radiation and outcome for recurrent high‐grade meningiomas. Future prospective randomized trials may help clarify the optimal tailored treatment for patients with high‐grade meningioma.
- 1 December 2018
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 7 (6) , 1666-1674
Intra-operative motor function preservation for resection of primary motor cortex meningioma
Background: Resection of meningioma located at primary motor cortex (PMC) is a great challenge to neurosurgeons due to the possibility of motor cortex injury and drainage venous damage during surgery. Here, we presented our experience in resection of PMC meningioma, with the assistance of preoperative multi-model image planning and intraoperative electrophysiological monitor. By these techniques, patients in our study achieved gross tumor resection (GTR) with appropriate motor cortex and drainage venous protection, and the patients recovered well with less neurologic deficits. Methods: Thirty patients of PMC meningioma were selected for the study during January 2014 to December 2015. All the patients were performed head magnetic resonance imaging (MRI), magnetic resonance venography (MRV) and functional MRI scan before surgery, then all the imaging data were transferred to dextroscope workstation for virtual reality (VR) planning, to display the relationship of tumor, drainage venous and motor cortex. During the operation, somatosensory-evoked potentials (SSEP) was firstly used to locate the central sulcus (CS) and define the PMC area. Then the tumors were carefully removed by avoiding damage the cortex and drainage venous. After tumor resection, motor-evoked potentials (MEP) was applied to evaluate the motor function reservation. Results: All the patients received preoperative image planning, and the relationships of tumor, drainage venous and motor cortex were clearly presented. With the application of SSEP monitor, the CS was firstly determined before tumor resection. Twenty-five cases in our study achieved radical resection of Simpson I, and 5 cases were Simpson II resection. After tumor resection, MEP monitor was used to confirm the preservation of motor function. Four patients suffered from moderate muscle strength decrease postoperatively, 10 patients experienced slight muscle strength decrease, while other 16 patients shared normal muscle strength as preoperative status. When discharge, those affected patients were recommended for further movement rehabilitation therapy. Conclusions: Preoperative multi-model image planning and intraoperative electrophysiological monitor are very useful techniques for resection of PMC meningioma. They could help decrease motor cortex damage and protect the drainage venous during surgery, which is much safer and benefit patient for better prognosis.
- 1 December 2018
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 7 (6) , 1666-1674
Intra-operative motor function preservation for resection of primary motor cortex meningioma
Background: Resection of meningioma located at primary motor cortex (PMC) is a great challenge to neurosurgeons due to the possibility of motor cortex injury and drainage venous damage during surgery. Here, we presented our experience in resection of PMC meningioma, with the assistance of preoperative multi-model image planning and intraoperative electrophysiological monitor. By these techniques, patients in our study achieved gross tumor resection (GTR) with appropriate motor cortex and drainage venous protection, and the patients recovered well with less neurologic deficits. Methods: Thirty patients of PMC meningioma were selected for the study during January 2014 to December 2015. All the patients were performed head magnetic resonance imaging (MRI), magnetic resonance venography (MRV) and functional MRI scan before surgery, then all the imaging data were transferred to dextroscope workstation for virtual reality (VR) planning, to display the relationship of tumor, drainage venous and motor cortex. During the operation, somatosensory-evoked potentials (SSEP) was firstly used to locate the central sulcus (CS) and define the PMC area. Then the tumors were carefully removed by avoiding damage the cortex and drainage venous. After tumor resection, motor-evoked potentials (MEP) was applied to evaluate the motor function reservation. Results: All the patients received preoperative image planning, and the relationships of tumor, drainage venous and motor cortex were clearly presented. With the application of SSEP monitor, the CS was firstly determined before tumor resection. Twenty-five cases in our study achieved radical resection of Simpson I, and 5 cases were Simpson II resection. After tumor resection, MEP monitor was used to confirm the preservation of motor function. Four patients suffered from moderate muscle strength decrease postoperatively, 10 patients experienced slight muscle strength decrease, while other 16 patients shared normal muscle strength as preoperative status. When discharge, those affected patients were recommended for further movement rehabilitation therapy. Conclusions: Preoperative multi-model image planning and intraoperative electrophysiological monitor are very useful techniques for resection of PMC meningioma. They could help decrease motor cortex damage and protect the drainage venous during surgery, which is much safer and benefit patient for better prognosis.
- 12 September 2018
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 140 (3) , 639-647
Clinical and prognostic features of spinal meningioma: a thorough analysis from a single neurosurgical center
Purpose The aim of this study was to thoroughly analyze the clinical characteristics of a large cohort of spinal meningioma (SM) from a single neurological center and identify risk factors associated with worse progression free survival and neurological function outcome. Methods Clinical information was retrieved from 483 SM and 9806 cranial meningioma cases who were operated in our center between 2003 and 2013. 194 SM patients who were followed at the main branch were used for prognostic analyses that included both recurrence free survival and neurological functions based on Modified McCormick scale (MMS). Results Females were predominant (P < 0.001). High grade tumors were not common (WHO grade II, 2.9%; grade III, 1.7%), while the clear cell subtype was frequent within grade II SMs (6/14, 42.9%). Macroscopic total resection was achieved in all SMs (Simpson grade I, 30.9%; grade II, 65.5%; grade III, 3.6%) with a low complications rate (4.6%) and provided neurological improvement in 80 patients (41.2%). Recurrence was seen in 9 cases (4.6%) and associated with high WHO grade, male, prior recurrence, and Simpson grade III. High WHO grade and high Ki-67 index were identified to be independent factors predictive of both neurological function deterioration and impaired post-operative neurological status. Conclusions Our analysis of the largest SM cohort in scale from a single institution offers a comprehensive view of the clinical characteristics of surgically treated SM, revealing the distinct biology of SM in comparison to its cranial counterparts, and providing guidance to improve surgical management of SM.
- 12 September 2018
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 140 (3) , 639-647
Clinical and prognostic features of spinal meningioma: a thorough analysis from a single neurosurgical center
Purpose The aim of this study was to thoroughly analyze the clinical characteristics of a large cohort of spinal meningioma (SM) from a single neurological center and identify risk factors associated with worse progression free survival and neurological function outcome. Methods Clinical information was retrieved from 483 SM and 9806 cranial meningioma cases who were operated in our center between 2003 and 2013. 194 SM patients who were followed at the main branch were used for prognostic analyses that included both recurrence free survival and neurological functions based on Modified McCormick scale (MMS). Results Females were predominant (P < 0.001). High grade tumors were not common (WHO grade II, 2.9%; grade III, 1.7%), while the clear cell subtype was frequent within grade II SMs (6/14, 42.9%). Macroscopic total resection was achieved in all SMs (Simpson grade I, 30.9%; grade II, 65.5%; grade III, 3.6%) with a low complications rate (4.6%) and provided neurological improvement in 80 patients (41.2%). Recurrence was seen in 9 cases (4.6%) and associated with high WHO grade, male, prior recurrence, and Simpson grade III. High WHO grade and high Ki-67 index were identified to be independent factors predictive of both neurological function deterioration and impaired post-operative neurological status. Conclusions Our analysis of the largest SM cohort in scale from a single institution offers a comprehensive view of the clinical characteristics of surgically treated SM, revealing the distinct biology of SM in comparison to its cranial counterparts, and providing guidance to improve surgical management of SM.
- 1 December 2017
- Published by Elsevier in World Neurosurgery
- Vol. 108, 465-473
Angiomatous Meningiomas Have a Very Benign Outcome Despite Frequent Peritumoral Edema at Onset
- 1 December 2017
- Published by Elsevier in World Neurosurgery
- Vol. 108, 465-473
Angiomatous Meningiomas Have a Very Benign Outcome Despite Frequent Peritumoral Edema at Onset
- 1 June 2016
- Published by Elsevier in World Neurosurgery
- Vol. 90, 414-419
Prognostic Factors in Patients with Primary Hemangiopericytomas of the Central Nervous System: A Series of 103 Cases at a Single Institution
- 1 June 2016
- Published by Elsevier in World Neurosurgery
- Vol. 90, 414-419
Prognostic Factors in Patients with Primary Hemangiopericytomas of the Central Nervous System: A Series of 103 Cases at a Single Institution